# Sandoz — media coverage

Sandoz was mentioned 41 times in 14 outlets across 5 countries over the last 12 months. 39% of that coverage was positive and 5% negative. 93% was editorial rather than PR or paid placement.

- Data as of: 2026-10-04 (window: last 365 days)
- Mentions (12 months): 41 (52 all-time)
- Outlets (12 months): 14 in 5 countries
- Average sentiment: +0.272 (39% positive, 5% negative)
- PR / editorial: 3 PR · 38 editorial
- Sector: Pharma
- Also written as: Novartis Sandoz, Sandoz Group, Sandoz Ltd

## Coverage over time (mentions per month)

| Month | Mentions |
|---|---|
| 2025-11 | 1 |
| 2025-12 | 1 |
| 2026-01 | 1 |
| 2026-02 | 3 |
| 2026-03 | 5 |
| 2026-04 | 3 |
| 2026-05 | 5 |
| 2026-06 | 10 |
| 2026-07 | 3 |
| 2026-08 | 9 |
| 2026-09 | 0 |
| 2026-10 | 0 |

## Top outlets (12 months)

| Outlet | Mentions |
|---|---|
|  | 20 |
| thepharmaletter.com | 5 |
| finance.yahoo.com | 4 |
| tradingview.com | 2 |
| ctinsider.com | 1 |
| europeanpharmaceuticalreview.com | 1 |
| finance.biggo.com | 1 |
| kimt.com | 1 |

## Countries (12 months)

| Country | Mentions |
|---|---|
| US | 20 |
| INT | 16 |
| CH | 2 |
| SI | 2 |
| ST | 1 |

## Share of voice among Pharma peers (12 months)

| Brand | Mentions |
|---|---|
| Eli lilly | 130 |
| Astrazeneca | 78 |
| Pfizer | 64 |
| Johnson & johnson | 59 |
| Novo nordisk | 46 |
| Merck | 44 |
| Sandoz | 41 |
| Moderna | 38 |
| Bayer | 36 |
| Roche | 36 |

## Recent coverage

- [Henlius and Sandoz Collaborate on Oncology Biosimilars Partnership - Labroots](https://www.labroots.com/trending/health-sciences-and-medical-research/30974/henlius-sandoz-collaborate-oncology-biosimilars-partnership-2/amp) — labroots.com, 2026-08-28, positive
- [Did Sandoz’s Expanded Henlius Biosimilar Pact Just Redraw Its (SWX:SDZ) Investment Narrative? - simplywall.st](https://simplywall.st/stocks/ch/pharmaceuticals-biotech/vtx-sdz/sandoz-group-shares/news/did-sandozs-expanded-henlius-biosimilar-pact-just-redraw-its) — simplywall.st, 2026-08-18, positive
- [Sandoz collaborates with Henlius on up to 10 biosimilars - The Pharma Letter](https://www.thepharmaletter.com/biosimilars-news/sandoz-collaborates-with-henlius-on-up-to-10-biosimilars) — thepharmaletter.com, 2026-08-17, positive
- [Henlius Partners with Switzerland's Sandoz to Launch Global Biosimilar Strategic Collaboration - finance.biggo.com](https://finance.biggo.com/news/402f85fa-0618-4ebc-afe9-11738a1b69db) — finance.biggo.com, 2026-08-16, positive
- [Sandoz to Pay Up to $322M for Biosimilars—Which Products? - Stock Titan](https://www.stocktitan.net/news/SDZNY/henlius-and-sandoz-enter-strategic-collaboration-to-unlock-global-tuecdwjy0dtw.html) — stocktitan.net, 2026-08-16, positive
- [Sandoz Inc. agrees to $469M settlement in generic drug price-fixing case, Tong says - CT Insider](https://www.ctinsider.com/connecticut/article/sandoz-generic-drug-price-fixing-settlement-ct-22375338.php) — ctinsider.com, 2026-08-06, negative
- [Minnesota gets $2M in Sandoz drug price-fixing settlement - KIMT](https://www.kimt.com/news/minnesota-gets-2m-in-sandoz-drug-price-fixing-settlement/article_abdaddb5-2567-414d-af76-8e7cd09aa36e.html) — kimt.com, 2026-08-04, positive
- [Sandoz Agrees to $450 Million Settlement With 43 US States Over Generic Drug Antitrust Claims - Pharmaceutical Executive](https://www.pharmexec.com/view/sandoz-agrees-450-million-settlement-43-us-states-over-generic-drug-antitrust-claims) — pharmexec.com, 2026-08-03, neutral

Data: VoilàIQ, 2026-10-04. Canonical: https://voilaiq.com/brand-catalog/sandoz